Tazarotene Recruiting Phase 3 Trials for Psoriasis Vulgaris (Plaque Psoriasis) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02611349Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
NCT02615093A Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis